150
Participants
Start Date
October 1, 2025
Primary Completion Date
October 30, 2028
Study Completion Date
December 30, 2028
Anlotinib+Cyclophosphamide+Vinorelbine
"Anlotinib hydrochloride capsules combined with Cyclophosphamide+Vinorelbine), Anlotinib hydrochloride capsules 8mg (weight ≤35kg) or 12mg (weight \> 35kg), po, qd, D1-D14;on an empty stomach ,Two weeks off for one week,with a cycle of 3 weeks.~Cyclophosphamide 25mg/m2, po, qd, D1-D28, with a cycle of 4 weeks. vinorelbine 60g/m2, po, qw, D1, 8,15, with a cycle of 4 weeks."
Cyclophosphamide+Vinorelbine
Cyclophosphamide 25mg/m2, po, qd, D1-D28, with a cycle of 4 weeks. vinorelbine 60mg/m2, po, qw, D1, 8,15, with a cycle of 4 weeks.
Sun Yat-sen University Cancer Center, Guangzhou
Sun Yat-sen University
OTHER